Phase III data presented at the ESMO 2014 Congress in Madrid, Spain reveals that a new drug called anamorelin, improves appetite and body mass in patients with advanced lung cancer who are suffering cancer anorexia. "Anorexia and cachexia are among the most troubling and distressing symptoms of advanced cancer, for both patients and their families," says the study's principal investigator, Dr Jennifer Temel from the Department of Medicine, Massachusetts General ...Sunday, 28 September 2014
Improve Appetite and Body Mass in Patients With Cancer Anorexia Noted With Anamorelin
Phase III data presented at the ESMO 2014 Congress in Madrid, Spain reveals that a new drug called anamorelin, improves appetite and body mass in patients with advanced lung cancer who are suffering cancer anorexia. "Anorexia and cachexia are among the most troubling and distressing symptoms of advanced cancer, for both patients and their families," says the study's principal investigator, Dr Jennifer Temel from the Department of Medicine, Massachusetts General ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment